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Abstract
©  2015  Wolters  Kluwer  Health,  Inc.  All  rights  reserved.  Objectives:  Preeclampsia  is  a
multisystem  disease  that  significantly  contributes  to  maternal  and  foetal  morbidity  and
mortality. In this study, we used a nonbiased microarray approach to identify novel circulating
miRNAs  in  maternal  plasma that  may  be  associated  with  preeclampsia.  Methods:  Plasma
samples were obtained at 16 and 28 weeks of gestation from 18 women who later developed
preeclampsia (cases) and 18 matched women with normotensive pregnancies (controls). We
studied miRNA expression profiles in plasma and subsequently confirmed miRNA and target
gene expression in placenta samples. Placental samples were obtained from an independent
cohort  of  19  women  with  preeclampsia  matched  with  19  women  with  normotensive
pregnancies.  Results:  From the microarray,  we identified one miRNA that  was significantly
differentially expressed between cases and controls at 16 weeks of gestation and six miRNAs
that were significantly differentially expressed at 28 weeks. Following qPCR validation, only one
miR-206 was found to  be significantly  increased in  28-week samples in  women who later
developed preeclampsia (1.4-fold change±0.2). The trend for increase in miR-206 expression
was mirrored within placental tissue from women with preeclampsia. In parallel, IGF-1, a target
gene of miR-206, was also found to be downregulated (0.41±0.04) in placental tissue from
women with preeclampsia. miR-206 expression was also detectable in myometrium tissue and
trophoblast cell lines. Conclusion: Our pilot study has identified miRNA-206 as a novel factor
upregulated in preeclampsia within the maternal circulation and in placental tissue.
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